Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.
about
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients.Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.Neurological and psychiatric associations in bullous pemphigoid - more than skin deep?Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.Bullous pemphigoid following the replacement of vildagliptin with anagliptin.Induced autoimmune bullous diseases.Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade.Linagliptin-induced bullous pemphigoid.Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of theThe Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
P2860
Q38614486-01695C32-47A4-44F9-A5D2-6873CD506B86Q38752194-609AE11B-EEEA-415A-9BC6-0EF9AF050E91Q39414522-837581C7-969E-45EB-B094-796AB1516ADEQ42378749-5CD086E9-0D17-4F85-ACAD-8AFB6AE6FFE0Q47988514-8587C25F-2718-41AD-97AC-1C62988279B0Q48127001-C436909C-ABD0-41BB-AF50-2693E7D1A530Q48157657-EA29605E-5037-4F6A-A836-84191A1FCA3BQ48187165-66029E4C-5F0E-4F43-8E39-03E8112F0CEAQ50063138-8CCA8211-98FB-49F7-8C9A-7F281AA50EDBQ54378899-ECD21259-7778-4847-8AD0-AA9C27864E86Q55154455-38C679AE-D2B2-4120-B54E-45BE44E7CBCCQ55260701-51107AA8-9BFB-4D6D-B29E-CE2B93E44C6DQ57490881-6B35A3AC-FBA5-4926-A956-7AE2143D2F30Q58735688-8695FC30-25E2-4DBD-ABA1-B51C74BC75BC
P2860
Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@en
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@nl
type
label
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@en
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@nl
prefLabel
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@en
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@nl
P2093
P2860
P356
P1476
Bullous pemphigoid and dipepti ...... ch Pharmacovigilance Database.
@en
P2093
D Hillaire-Buys
French Association of Regional PharmacoVigilance Centres
J Micallef
P2860
P304
P356
10.1111/BJD.14601
P407
P577
2016-03-31T00:00:00Z